We are live on !
Find out more
Grace Capital Portfolio holdings
AUM
$168M
Turnover
17.96%
1-Year Est. Return
21.6%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
–
AUM
$168M
AUM Growth
+$5.88M
(+3.6%)
Cap. Flow
+$7.04M
Cap. Flow % of AUM
Cap. Flow %
4.18%
Top 10 Holdings %
Top 10 Hldgs %
32.21%
Holding
167
New
6
Increased
63
Reduced
19
Closed
24
Avg Time Held
2.6
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Consumer Discretionary ETF
VCR
|
+$6.52M |
| 2 |
Jasper Therapeutics
JSPR
|
+$2.04M |
| 3 |
Tesla
TSLA
|
+$1.9M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$928K |
| 5 |
NeoGenomics
NEO
|
+$619K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$942K |
| 2 |
State Street Blackstone Senior Loan ETF
SRLN
|
+$918K |
| 3 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$915K |
| 4 |
Vanguard Health Care ETF
VHT
|
+$905K |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$892K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.02% |
| 2 | Technology | 18.67% |
| 3 | Healthcare | 17.23% |
| 4 | Consumer Discretionary | 9.91% |
| 5 | Financials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
AbbVie
ABBV
$505B
| $379K | 0.23% |
2,800
+600
| +27% | +$70.9K |
2018 Q2
14 quarters
|
|
102
Digital Realty Trust
DLR
$63.9B
| $375K | 0.22% |
2,124
-10
| -0.5% | -$1.6K |
2017 Q3
17 quarters
|
|
103
Golar LNG
GLNG
$4.66B
| $372K | 0.22% |
30,000
| – | – |
2018 Q2
14 quarters
|
|
104
Norfolk Southern
NSC
$74.1B
| $361K | 0.21% |
+1,211
| New | +$338K |
2021 Q4
0 quarters
|
|
105
Mastercard
MA
$546B
| $359K | 0.21% |
1,000
| – | – |
2019 Q1
11 quarters
|
|
106
Phillips 66
PSX
$113B
| $348K | 0.21% |
4,800
+3,850
| +405% | +$291K |
2018 Q2
14 quarters
|
|
107
Cognyte Software
CGNT
$721M
| $334K | 0.2% |
19,800
| – | – |
2021 Q1
3 quarters
|
|
108
IPG Photonics
IPGP
$3.02B
| $327K | 0.19% |
1,900
+300
| +19% | +$49.6K |
2018 Q2
14 quarters
|
|
109
Biogen
BIIB
$37B
| $312K | 0.19% |
1,300
| – | – |
2017 Q4
16 quarters
|
|
110
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$227M
| $307K | 0.18% |
7,150
+1,300
| +22% | +$63K |
2019 Q3
9 quarters
|
|
111
Global X US Preferred ETF
PFFD
$1.97B
| $303K | 0.18% |
11,780
+2,530
| +27% | +$64.8K |
2021 Q3
1 quarter
|
|
112
Workday
WDAY
$50.6B
| $300K | 0.18% |
1,100
| – | – |
2020 Q3
5 quarters
|
|
113
Waters Corp
WAT
$44.6B
| $298K | 0.18% |
800
+100
| +14% | +$35K |
2018 Q2
14 quarters
|
|
114
City Holding Co
CHCO
$1.99B
| $296K | 0.18% |
3,620
+130
| +4% | +$10.4K |
2020 Q3
5 quarters
|
|
115
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.91B
| $293K | 0.17% |
8,300
| – | – |
2020 Q4
4 quarters
|
|
116
Weyerhaeuser
WY
$14B
| $292K | 0.17% |
7,100
+1,600
| +29% | +$60.8K |
2018 Q2
14 quarters
|
|
117
Dow Inc
DOW
$23.6B
| $284K | 0.17% |
5,000
| – | – |
2019 Q3
9 quarters
|
|
118
Salesforce
CRM
$205B
| $276K | 0.16% |
1,085
-63
| -5% | -$17.7K |
2021 Q2
2 quarters
|
|
119
Okta
OKTA
$37.2B
| $275K | 0.16% |
1,228
+19
| +2% | +$4.53K |
2021 Q1
3 quarters
|
|
120
DELISTED
Immunogen Inc
IMGN
| $275K | 0.16% |
37,000
+9,000
| +32% | +$55.9K |
2018 Q2
14 quarters
|
|
121
Dollar Tree
DLTR
$23.5B
| $267K | 0.16% |
1,900
| – | – |
2019 Q4
8 quarters
|
|
122
US Physical Therapy
USPH
$1.32B
| $257K | 0.15% |
2,690
-77
| -3% | -$7.72K |
2020 Q2
6 quarters
|
|
|
MMP
123
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $247K | 0.15% |
+5,310
| New | +$251K |
2021 Q4
0 quarters
|
|
124
Zoetis
ZTS
$33.5B
| $244K | 0.14% |
1,000
| – | – |
2020 Q3
5 quarters
|
|
125
Vontier
VNT
$4.65B
| $237K | 0.14% |
7,700
+1,500
| +24% | +$48.9K |
2020 Q4
4 quarters
|
|
Similar funds
REMS
TI
NM
KM
MC
FAC
ACM
Grace Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Grace Capital held 167 positions worth $168M, up 3.6% from $163M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Grace Capital deployed $7.04M of net new capital in Q4 2021, opening 6 new positions and adding to 63 existing holdings. Its largest new stake was Jasper Therapeutics: 21,811 shares worth $1.71M.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Ares Capital, an estimated $415K trimmed.
- Grace Capital's largest Q4 2021 buy was Jasper Therapeutics: 21,811 shares worth $1.71M.
- Grace Capital added most to Vanguard Consumer Discretionary ETF in Q4 2021, an estimated $6.52M increase.
- Grace Capital's biggest Q4 2021 reduction was Ares Capital, cutting an estimated $415K.
- Grace Capital fully exited Vanguard Real Estate ETF in Q4 2021, selling an estimated $942K.
- Grace Capital's ten largest holdings make up 32% of its $168M portfolio in Q4 2021.
- Grace Capital opened 6 new positions and closed 24 in Q4 2021.
- Grace Capital's portfolio value rose 3.6% quarter-over-quarter to $168M.
Based on Grace Capital's 13F filing for Q4 2021, filed 2 Feb 2022.